Stock Price
23.14
Daily Change
-0.11 -0.47%
Monthly
-0.17%
Yearly
14.84%
Q2 Forecast
22.52

EPS Reference Time Actual Consensus Previous
2026-05-05 FY2026Q1 0.18 0.14
2026-03-03 FY2025Q4 0.18 0.2 0.20
2025-11-04 FY2025Q3 0.21 0.18 0.17
2025-08-05 FY2025Q2 0.23 0.17 0.20
2025-05-06 FY2025Q1 0.14 0.18 0.12



Peers Price Chg Day Year Date
Alliar Medicos A Frente 3.17 -0.01 -0.31% -47.17% Apr/17
Marisa Lojas 0.89 0 0% -37.32% Apr/17
Arezzo Industria e Comercio 22.12 -0.10 -0.45% -21.00% Apr/17
Americanas 6.98 -0.63 -8.28% 17.91% Apr/17
C&A Modas 13.27 0.22 1.69% 4.82% Apr/17
Clicks 30,014.00 953.00 3.28% -21.98% Apr/17
Grup SBF 13.40 0.38 2.92% 28.87% Apr/17
Cogna Educacao 3.27 0.03 0.93% 29.18% Apr/17
Fleury 16.65 -0.44 -2.57% 34.49% Apr/17
Fomento Economico Mexicano 117.72 0.76 0.65% 12.65% Apr/17

Indexes Price Day Year Date
IBOVESPA 195734 -1,085.08 -0.55% 50.03% Apr/17

Raia Drogasil traded at 23.14 this Friday April 17th, decreasing 0.11 or 0.47 percent since the previous trading session. Looking back, over the last four weeks, Raia Drogasil lost 0.17 percent. Over the last 12 months, its price rose by 14.84 percent. Looking ahead, we forecast Raia Drogasil to be priced at 22.52 by the end of this quarter and at 20.75 in one year, according to Trading Economics global macro models projections and analysts expectations.

Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.